Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) is prescribed as a once-weekly injection, and that seven-day gap is the interval tested in clinical trials and approved by the MHRA for weight management in the UK. Taking it five days apart shortens the cycle, which can affect how the medicine behaves in your body and is not in line with the licensed schedule — your prescriber is the right person to advise if timing genuinely needs adjusting. These are prescription-only medicines, and dosing decisions rest with the clinician who oversees your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide builds up in your system gradually over the first few weeks of treatment. That steady accumulation is deliberate, it is part of why the titration schedule starts low (0.25 mg) and moves upward slowly, so your body adjusts before the dose increases. The seven-day interval keeps the concentration in your blood relatively stable between injections.
Shorten the gap to five days consistently and you are effectively dosing more frequently than the medicine was designed for. Over time that can shift the balance between efficacy and tolerability. The MHRA-approved schedule exists because that is what was tested across thousands of participants in the clinical programme, including the STEP 1 trial published in the New England Journal of Medicine, which demonstrated around 15% average weight loss over 68 weeks at the 2.4 mg maintenance dose. Departing from that schedule means stepping outside the evidence base.
A simple checking habit worth building: before you inject, count seven days from the date on your last pen label or set a weekly phone reminder. It takes under a minute and removes the guesswork entirely. The Wegovy treatment overview explains how the titration steps fit together if you want the fuller picture.
The Wegovy Patient Information Leaflet does include a reference to five days in one specific context: if you miss your usual injection day and remember later in the week, you can take it provided there are at least five days remaining until your next scheduled dose. If there are fewer than five days, you skip that dose and resume on your normal day.
That five-day minimum is a recovery rule for occasional missed doses. It is not permission to restructure your schedule around a five-day cycle. Using it as a regular pattern would mean you are injecting roughly every five days rather than every seven, adding approximately two extra doses per month. That is a significant departure from the licensed regimen, and one your prescriber has not assessed you for.
There is an important distinction here between a one-off timing rescue and a deliberate change in how you use the medicine. The NHS medicines page for semaglutide sets out what to do with missed doses clearly, and it is worth reading alongside your leaflet if you are unsure.
Some people find that a fixed weekly day is hard to maintain, shift patterns, travel, childcare, work schedules. That is a real and practical problem, not a minor one. The right response is to talk it through with your prescriber rather than quietly adjusting the gap.
A prescriber can help you pick a consistent injection day that works across your routine, sometimes it is simply a case of moving from, say, Monday to Thursday as a permanent change, rather than improvising each week. If you are injecting every five days because you keep forgetting and then catching up, reminders on your phone or a note on the fridge can solve the underlying issue without changing the medicine schedule at all.
If you are finding that travel or other commitments affect when you can inject, the question of taking Wegovy through airport security is something our clinical team covers in detail separately. And if your question is really about flexibility in either direction (injecting a little earlier or a day or two later) our pages on taking Wegovy two days early and extending to a six-day interval walk through those scenarios with the same level of care.
Cost sometimes sits behind scheduling questions too, people wonder whether spacing doses out further would make the pens last longer. If that is part of your thinking, the guide to where Wegovy is available in the UK covers what to look for in a provider, and our treatment page is the clearest place to see what a private prescription route includes.
Contact your prescriber or aftercare team if you have already been injecting more frequently than weekly and are worried about what that means, if your side effects feel more intense than usual, or if you are unsure whether you have taken a dose at all. These are not embarrassing questions. A clinician who sees Wegovy patients regularly will have heard all of them.
Our prescribers at nume review every repeat order before it is dispensed, there is no automated repeat. That means your dosing history and any concerns you have raised are part of the clinical picture each time, not something you have to explain from scratch. If you want to discuss a scheduling issue, the contact page connects you to our aftercare team seven days a week.
For anyone not yet on treatment and wondering whether Wegovy fits their situation, checking your BMI eligibility for Wegovy is a useful first step before a consultation. Speak to our prescribers through a free consultation to understand what is clinically right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.